Research and analysis

3M™ Tegaderm™ CHG Chlorhexidine Gluconate IV securement dressing review

Part of the Department of Health’s Healthcare Associated Infections Technology Innovation Programme.


Showcase Hospitals Local Technology Review Report number 5

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


Showcase Hospitals undertook local technology reviews of infection related products or technologies in which they have a specific interest.

Imperial College Healthcare NHS Trust decided to review the 3M™ Tegaderm™ CHG Chlorhexidine Gluconate IV Securement Dressing which is a transparent adhesive dressing with an integrated gel pad containing chlorhexidine gluconate (CHG). The dressing is used in addition to skin antiseptic delivering CHG over a seven day period to the skin around the catheter insertion site, reducing the risk of possible infections leading to catheter related bloodstream infections.

3M™ Tegaderm™ CHG Dressing was evaluated over a four month period from January to April 2011. The cost of 1000 dressings equates to a single avoidable healthcare associated infection which is estimated to cost the NHS £7,000. The cost of treating a bloodstream infection is likely to be higher as length of stay in hospital is much longer.

The objective of local technology reviews is to help directors of infection prevention and control and other stakeholders to decide whether they should consider any of these products or technologies as part of their trust’s strategy to reduce healthcare associated infections.

Published 3 August 2012